The defining molecular feature of the tumor is the characteristic FET::ETS fusion involving: EWSR1::FLI1 (70–80%) and EWSR1/FUS::ERG fusions (15%), followed by EWSR1/FUS::FEV (5%), and EWSR1::ETV1/4 (1%)18. This evidence concerns the gene FUS and neoplasm.